Lancaster University Scientists have developed a COVID-19 vaccine that can be delivered via a nasal spray. In a preclinical trial, the vaccine was found to decrease both disease severity and transmission of the virus. The study results are published in the journal iScience.
In this interview, Kevin Wyndham, senior director of research and development at Waters, highlights how a new LC-MS method could be used to support research both during and beyond the COVID-19 pandemic.
Enteric Disease: The Achilles Heel of Oral Vaccines technologynetworks.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from technologynetworks.com Daily Mail and Mail on Sunday newspapers.
Smart Bandage Keeps an Eye on Wounds | Clinical And Molecular Dx labroots.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labroots.com Daily Mail and Mail on Sunday newspapers.
The U.S. new cases 7-day rolling average are 52.2 % HIGHER than the 7-day rolling average one week ago and U.S. deaths due to coronavirus are now 27.1 %
HIGHER than the rolling average one week ago. Today s posts include:
U.S. Coronavirus New Cases are 55,828
U.S. Coronavirus deaths are at 622
Covid-19 breakthrough infections are preventable, but it s going to take a big effort to stop them
Which SARS-CoV-2 vaccine should I get, if any? - The model simulated the health outcomes for a 65-year-old and found the patient would gain a net of 7.4 days an extra week of life if the person received the mRNA vaccine versus opting to not vaccinate at all.